Analgesia for acute soft-tissue limb conditions

Busse, 2020Jones, 2020Qaseem, 2020Morelli 2018

Not all people with acute soft-tissue limb conditions will require analgesia. A 2020 Cochrane review1 found that in acute soft-tissue injury, nonsteroidal anti-inflammatory drugs (NSAIDs) (when compared with paracetamol) made no difference to pain at 1 to 2 hours or at 2 to 3 days, and may make no difference at day 7 and beyondJones, 2020.

Paracetamol and NSAIDs are often used for short-term pain relief by people with acute soft-tissue limb conditions. If analgesia is required for an acute soft-tissue limb condition, first-line treatment is oral paracetamol; use:

1paracetamol immediate-release 1 g orally, 4- to 6-hourly, up to a maximum of 4 g daily paracetamol paracetamol paracetamol

OR

1paracetamol modified-release 1.33 g orally, 8-hourly. paracetamol paracetamol paracetamol

If the analgesic effect from paracetamol is inadequate, an NSAID may be used instead of, or in combination with, paracetamol.

For superficial soft-tissue limb conditions (eg de Quervain tenosynovitis), topical NSAIDs are considerably safer than oral NSAIDs because of minimal systemic absorption. If a trial of a topical NSAID is considered appropriate for a superficial soft-tissue limb condition, useBusse, 2020Qaseem, 2020:

1diclofenac 1% gel applied to the painful area, up to 4 times daily if required diclofenac diclofenac diclofenac

OR

1diclofenac 2% gel applied to the painful area, once or twice daily if required diclofenac diclofenac diclofenac

OR

1ibuprofen 5% gel applied to the painful area, up to 4 times daily if required ibuprofen ibuprofen ibuprofen

OR

1piroxicam 0.5% gel applied to the painful area, up to 4 times daily if required. piroxicam piroxicam piroxicam

All of the NSAIDs listed below are equally effective, and drug choice should be based on patient factors (eg comorbidities); see Choosing an NSAID for advice on drug choice. If an oral NSAID is indicated for a soft-tissue limb condition, use:

1celecoxib 100 to 200 mg orally, daily in 1 or 2 divided doses, until symptoms subside celecoxib celecoxib celecoxib

OR

1etoricoxib 30 to 60 mg orally, daily until symptoms subside etoricoxib etoricoxib etoricoxib

OR

1ibuprofen immediate-release 200 to 400 mg orally, 3 or 4 times daily until symptoms subside ibuprofen ibuprofen ibuprofen

OR

1indometacin 25 to 50 mg orally, 2 to 4 times daily until symptoms subside indometacin indometacin indometacin

OR

1ketoprofen modified-release 200 mg orally, daily until symptoms subside ketoprofen ketoprofen ketoprofen

OR

1meloxicam 7.5 to 15 mg orally, daily until symptoms subside meloxicam meloxicam meloxicam

OR

1naproxen immediate-release 250 to 500 mg orally, twice daily until symptoms subside naproxen naproxen naproxen

OR

1naproxen modified-release 750 to 1000 mg orally, daily until symptoms subside naproxen naproxen naproxen

OR

1piroxicam 10 to 20 mg orally, daily until symptoms subside piroxicam piroxicam piroxicam

OR

2diclofenac 25 to 50 mg orally, 2 or 3 times daily until symptoms subside. diclofenac diclofenac diclofenac

The potential benefits of an NSAID should be weighed against its potential harms, particularly in people at high risk of harms (see Principles of NSAID use for musculoskeletal pain for more information).

Other analgesic therapies that may be considered for acute soft-tissue limb conditions include local anaesthetic nerve blocks and acupuncture. Opioids are rarely indicated for acute soft-tissue limb injuries and are associated with a significant risk of harms.

Local corticosteroid injections can be used for analgesia in people with tendinopathy for short-term pain relief (6 to 8 weeks). They are not recommended for acute soft-tissue conditions, including muscle strain and ligament sprain.

1 Jones P, Lamdin R, Dalziel SR. Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Database Syst Rev 2020;8(8):CD007789. [URL]Return